| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689265 | European Urology | 2017 | 4 Pages |
Abstract
We studied the levels of two proteins (pSTAT3 and IL6R) in metastases from patients who died from castration-resistant prostate cancer. We found high levels of pSTAT3and IL6R in bone metastases, suggesting that these proteins could be used as targets for new anticancer drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Nicholas Don-Doncow, Felicia Marginean, Ilsa Coleman, Peter S. Nelson, Roy Ehrnström, Agnieszka Krzyzanowska, Colm Morrissey, Rebecka Hellsten, Anders Bjartell,